Press Releases 2013
Press Releases 2012
Press Releases 2011
Press Releases 2010
Press Releases 2009
Press Releases 2008
Press Releases 2007
Press Releases 2006
Press Releases 2005
Press Releases 2004
Press Releases 2003
10.24.06
Linaclotide Shown to Improve Symptoms of Chronic Constipation in Phase 2A Study
05.23.06
Microbia Presents MD-1100 (Linaclotide Acetate) Phase 1 Results
Clinical Study Showed that Linaclotide Exhibited Encouraging Gastrointestinal Pharmacodynamics and No Detectable Systemic Exposure
04.06.06
George Conrades joins Microbia Board of Directors
Executive Chairman of Akamai
02.27.06
Microbia Raises $75 Million in Private Equity Financing to Advance Therapeutic Candidates through Clinical Trials
Company-Sponsored Phase 2 Trial Initiated for
MD-1100, Novel GI Treatment
Lisa Buffington
VP, Corporate Communications
617.374.5103
lbuffington@ironwoodpharma.com
Copyright © 2013, Ironwood Pharmaceuticals, Inc.
All Rights Reserved
|
Privacy Policy
|
Terms of Service
|
Site Design
